These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 2667547)

  • 1. How to evaluate a drug efficacy at the behavioural level?
    Aquino JP; Poitrenaud J
    Arch Gerontol Geriatr Suppl; 1989; 1():249-53. PubMed ID: 2667547
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical trials in memory disorders: objectives and methodology.
    Alperovitch A
    Arch Gerontol Geriatr Suppl; 1989; 1():207-14. PubMed ID: 2757734
    [No Abstract]   [Full Text] [Related]  

  • 3. Medicine's next level.
    Carmichael M
    Newsweek; 2004 Dec; 144(23):44-6, 49-50. PubMed ID: 15605719
    [No Abstract]   [Full Text] [Related]  

  • 4. Forgetting and remembering. A star-studded search for memory-enhancing drugs.
    Marshall E
    Science; 2004 Apr; 304(5667):36-8. PubMed ID: 15060299
    [No Abstract]   [Full Text] [Related]  

  • 5. [Experience with phosphatidylserine treatment of patients with cognitive and behavioral decline].
    Marcon GM; Mascolo MD
    Clin Ter; 1988 Aug; 126(4):243-8. PubMed ID: 2974392
    [No Abstract]   [Full Text] [Related]  

  • 6. Pentylenetetrazol in the treatment of geriatric patients with disturbed memory function.
    Leckman J; Ananth JV; Ban TA; Lehmann HE
    J Clin Pharmacol New Drugs; 1971; 11(4):301-3. PubMed ID: 4932747
    [No Abstract]   [Full Text] [Related]  

  • 7. [Phosphatidylserine and memory disorders in the aged].
    Nerozzi D; Aceti F; Melia E; Magnani A; Marino R; Genovesi G; Amalfitano M; Cozza G; Murgiano S; De Giorgis G
    Clin Ter; 1987 Mar; 120(5):399-404. PubMed ID: 3034480
    [No Abstract]   [Full Text] [Related]  

  • 8. [Modification of memory disturbances after electroshock with centrophenoxine].
    Vojtĕchovský M
    Arzneimittelforschung; 1970 Jul; 20(7):882-4. PubMed ID: 4918917
    [No Abstract]   [Full Text] [Related]  

  • 9. [Memory: therapeutic approach. Clinical evaluation].
    Pasquier F
    Therapie; 2000; 55(4):513-9. PubMed ID: 11098729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inclusion and exclusion clinical criteria to form homogeneous groups of patients in the therapeutic trials of a memory enhancing drug.
    Piette F
    Arch Gerontol Geriatr Suppl; 1989; 1():195-200. PubMed ID: 2757732
    [No Abstract]   [Full Text] [Related]  

  • 11. Long-term outpatient treatment of senile dementia with oral physostigmine.
    Beller SA; Overall JE; Rhoades HM; Swann AC
    J Clin Psychiatry; 1988 Oct; 49(10):400-4. PubMed ID: 3049561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of galantamine on verbal repetition in AD: a secondary analysis of the VISTA trial.
    Wong VS
    Neurology; 2007 Aug; 69(8):809; author reply 809-10. PubMed ID: 17709718
    [No Abstract]   [Full Text] [Related]  

  • 13. Drug development in age-related memory disorders.
    Guez D
    Arch Gerontol Geriatr Suppl; 1989; 1():191-4. PubMed ID: 2667542
    [No Abstract]   [Full Text] [Related]  

  • 14. Problems of a drug trial (Pemoline) on geriatric patients.
    Droller H; Bevans HG; Jayaram VK
    Gerontol Clin (Basel); 1971; 13(5):269-76. PubMed ID: 4939854
    [No Abstract]   [Full Text] [Related]  

  • 15. [Therapeutic correction of senile behavior characteristics with Wallerox. Contribution on experimental psychological geriatrics].
    Oswald WD; Müller-Egloff P; Becker E; Wilde M
    Munch Med Wochenschr; 1969 Jun; 111(26):1444-8. PubMed ID: 4980146
    [No Abstract]   [Full Text] [Related]  

  • 16. A logical approach to the clinical assessment of cerebro-active drugs.
    Wertheimer J
    Arch Gerontol Geriatr Suppl; 1989; 1():201-5. PubMed ID: 2757733
    [No Abstract]   [Full Text] [Related]  

  • 17. Scopolamine-induced deficits in social memory in mice: reversal by donepezil.
    Riedel G; Kang SH; Choi DY; Platt B
    Behav Brain Res; 2009 Dec; 204(1):217-25. PubMed ID: 19527754
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Memory enhancement: the search for mechanism-based drugs.
    Lynch G
    Nat Neurosci; 2002 Nov; 5 Suppl():1035-8. PubMed ID: 12403980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of the effect of vincamine teprosilate on behavioural performances of patients affected with chronic cerebrovascular disease.
    Casale R; Giorgi I; Guarnaschelli C
    Int J Clin Pharmacol Res; 1984; 4(4):313-9. PubMed ID: 6500778
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Tacrine].
    Dávila C; Viteri C; de Castro P
    Rev Med Univ Navarra; 1997; 41(1):58-64. PubMed ID: 9527715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.